SUBSCRIBE
SUBSCRIBE

GlaxoSmithKline

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Pfizer Semi-Officially Abandons GlaxoSmithKline Bid and Turns Gaze to Allergan
November 3, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Big Meetings This Week with GlaxoSmithKline, Roche, Sanofi Have Investors on Pins and Needles
November 2, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Prominent Fund Manager Urges GlaxoSmithKline to Break Up
October 26, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Third Rock Ventures and GlaxoSmithKline’s SR One Launch Decibel Therapeutics With $52 Million, Expect to Hire 50-60 By Year End
October 15, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
GlaxoSmithKline Slaps “For Sale” Sign on Huge Pittsburgh Campus
October 2, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
GlaxoSmithKline to Shutter R&D Site in France and Shift Work to UK and US
September 25, 2015
 · 
2 min read
Re-Analysis of GlaxoSmithKline’s Seroxat/Paxil Antidepressant Data Shows Lack of Transparency
Policy
Re-Analysis of GlaxoSmithKline’s Seroxat/Paxil Antidepressant Data Shows Lack of Transparency
September 17, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Genetown
Agenus Trades Away Future Royalties on Sales of GlaxoSmithKline Drug for $115 Million
September 9, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
GlaxoSmithKline, Theravance’s Breo Fails to Extend Lives in Ambitious Study
September 8, 2015
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Deals
GlaxoSmithKline Eyes Tasty $1.5 Billion for Lucozade, Ribena
April 25, 2013
 · 
1 min read
GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results
April 24, 2013
 · 
1 min read
Business
$495 Million Deal Between GlaxoSmithKline and Avalon to Form Up to 10 Biotechs in San Diego
April 23, 2013
 · 
1 min read
Policy
GlaxoSmithKline and Theravance, Inc. Announce Regulatory Submission for ANORO™ ELLIPTA™ (UMEC/VI) in Japan
April 22, 2013
 · 
6 min read
Drug Development
Astellas Pharma Inc., GlaxoSmithKline Vie to Make “High Altitude” Anemia Pill
April 19, 2013
 · 
1 min read
Pharm Country
GlaxoSmithKline Issues Call for Applications Totaling $400,000 in GSK IMPACT Awards
April 19, 2013
 · 
3 min read
BioCapital
GlaxoSmithKline’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment
April 18, 2013
 · 
1 min read
FDA
FDA Panel Backs Approval of GlaxoSmithKline, Theravance, Inc. Lung Drug
April 18, 2013
 · 
8 min read
Policy
Supreme Court Denies GlaxoSmithKline Appeal Over Humana Avandia Suit
April 16, 2013
 · 
1 min read
FDA
GlaxoSmithKline’s Avandia Gets Second Look at Heart Risk by U.S.
April 12, 2013
 · 
1 min read
Load More